Many more speakers to be confirmed in the coming weeks!

ICPR 2022 Confirmed Speakers

Katrin Preller

Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, Switzerland

David Nichols

Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Kim Kuypers

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Rick Doblin

Founder and Executive Director at MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Amanda Feilding

Founder and Executive Director of the Beckley Foundation, United Kingdom

David Nutt

Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Erika Dyck

Professor and Canada Research Chair in the History of Health & Social Justice at the University of Saskatchewan

Roland Griffiths

Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University, United States

Gitte Moos Knudsen

Chair, Professor at Dept. Neurology and Neurobiology Research Unit, Copenhagen University Hospital, Denmark

Paul Stamets

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Friederike Holze

Postdoctoral researcher at University Hospital Basel, Switzerland

Peter Gasser

Psychiatrist and Psychotherapist / President of Swiss Medical Society for Psycholytic Therapy, Switzerland

Janis Phelps

Director of the CIIS Center for Psychedelic Therapies and Research, United States

Mendel Kaelen

Founder and CEO at Wavepaths, United Kingdom

Monnica Williams

Research Chair for Mental Health Disparities, University of Ottawa. Principal Investigator for a multi-site study on MDMA-assisted psychotherapy for PTSD, Canada

Bernardo Kastrup

Executive Director of Essentia Foundation / Author, Philosopher, Computer Scientist, the Netherlands

Sonya Faber

Partner at Bioville Gmbh & MSL at Angelini Pharma. BoD member at Chacruna Institute, United States

Matthias Liechti

Professor of clinical pharmacology and internal medicine at the University Hospital Basel

Torsten Passie

Professor of Psychiatry and Psychotherapy at Hannover Medical School, Germany

Charles Raison

Director of Clinical and Translational Research for Usona Institute. Director of Research on Spiritual Health for Emory Healthcare, United States

Ian Roullier

Co-Founder of the Psychedelic Participant Advocacy Network (PsyPAN), United Kingdom

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

Want The Latest Updates?

Subscribe below to ICPR Newsletter and get all the latest updates, including discount tickets!

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy & terms.